310 likes | 333 Views
This presentation delves into analyzing basket designs in oncology, discussing Bayesian hierarchical models, recruitment strategies, and futility analysis methods. It explores the adjustment of models for target rates and decision-making processes for different cohorts based on interim and final analyses. Presented on May 24, 2019, in Lyon, France.
E N D
Exploring early interim analyses in basket designs in Oncology Oliver Sailer, Anna Pöhlmann, Frank Fleischer 24 May 2019, BAYES2019, Lyon, France
Basket designs and Bayesian hierarchical model Presentation title, date, author
Basket designs • Basket trial* • One experimental treatment • (Patients with similar genomic features) • Different disease types (Renfro and Sargent, 2016) • Questions • Does the treatment work sufficiently? • Can we identify cohorts with a promising effect? * Renfro and Sargent (2016) Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Basket designs - analysis approaches Pooling Stratification • Assumes the same underlying response rate in all cohorts • Potentially large bias • Assumes independent cohorts • Low precision • Bayesian hierarchical model (BHM) • Assumes exchangeability between cohorts • Parameter of between-cohort variation determines the extent of borrowing Exploring early interim analyses in basket designs in Oncology, 24 May 2019
BHM adjusting for target rate (Berry et al., 2013) • Random cohort effect in terms of log-odds of response rate • Likelihood • Prior • Implementation: R interface to JAGS, R2JAGS package Exchangeabilityof log-odds after adjustingfortargetrates Informative prior on between-cohortvariability; scaleparameterchoiceseeNeuenschwander et al. 2015 Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Presentation title, date, author
Recruitment and analysis strategies • Interim analyses performed to limit exposure of additional patients to an ineffective drug • Futility could be based on within-cohort analysis only or borrow information across cohorts • Possible consequences of futility • Stop recruitment into cohort • Do not develop drug further for cohort (no-go) • Exclude cohort from later analyses (“test-then-pool”, Viele et al. 2013 ) Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 1 cons cons cons I go go go F cons nogo I F cons nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 1 cons cons cons I go go go F cons nogo I F cons Interim futilityanalysis Decisionforcohort i useonlydataofcohort i nogoif <r responders nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 1 cons cons cons Final analysis Decisionforcohort i use all datafrom all cohorts based on posterior of BHM I go go go F cons nogo I F cons nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 2 cons cons cons I go go go F cons nogo I Interim futilityanalysis Decisionforcohort i use all datafrom all cohorts based on posterior of BHM F cons nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 2 cons cons cons Final analysis Decisionforcohort i use all datafrom all cohorts based on posterior of BHM I go go go F cons nogo I F cons nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 3 cons cons cons I go go go F cons nogo I F cons Interim futilityanalysis Decisionforcohort i useonlydataofcohort i nogoif <r responders nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else nogo nogo nogo nogo • Strategy 3 cons cons cons Final analysis Decisionforcohort i use all datafrom non-futile cohorts based on posterior of BHM I go go go F cons nogo I F cons nogo I F cons Recruitment I: Interim (herefutility) F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else • Strategy 4 Interim / final analysis Decisionforcohort i use all datafrom all cohorts based on posterior of BHM I I III … I F Recruitment I: Interim F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies Overall go at firstcohortgo Overall nogoif all cohortsnogo Overall consider, else • Strategy 4 X Interim / final analysis Decisionforcohort i use all datafrom all cohorts based on posterior of BHM In caseofinterimfutility, stoprecruitmentforcohort X I I III … I F Recruitment I: Interim F: Final Time Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Model-baseddecisionrule Cohort i NoGoConsider Go q50,i median posteriorresponse rate cohort i c1,i, c2,icohortspecificdecisionboundary Variation qg,ig-quantileofposteriordistribution q50,i > c2,i q50,i < c1,i else q1-g,i > c2,i qg,i < c1,i else Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Recruitment and analysis strategies • Strategy 1-3: Futility after 10 patients, final after 20 (per cohort) • Strategy 4: Interim analysis every 5 patients, Final at 4*20 max. Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Response scenarios Presentation title, date, author
Response scenarios • Positive and negative scenarios • Positive nugget scenario • Mixed response scenario Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Model parameters Presentation title, date, author
Model parameters • Model adjustment parameter • Controls borrowing • Target rate by cohort set to assumed response rate if drug works (as in Berry et al 2013) • Inter-cohort variability prior • = 0.5 allows for range of up to substantial heterogeneity Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Operating characteristics Presentation title, date, author
Operating characteristics • Decision probabilities in scenarios • Average sample size and duration Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Simulation results Presentation title, date, author
Scenario 1 NoGo, Consider, Go: Probability in %, N average number evaluable, t average duration (months) Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Scenario 2 NoGo, Consider, Go: Probability in %, N average number evaluable, t average duration (months) Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Scenario 3 NoGo, Consider, Go: Probability in %, N average number evaluable, t average duration (months) Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Scenario 4 NoGo, Consider, Go: Probability in %, N average number evaluable, t average duration (months) Exploring early interim analyses in basket designs in Oncology, 24 May 2019
References • Berry SM, Broglio KR, Groshen S, and Berry DA (2013): Bayesianhierarchicalmodelingofpatientsubpopulations: efficientdesignsofphase II oncologyclinicaltrials. Clinical Trials, 10(5), 720-734. • NeuenschwanderB, Wandel S, Roychoudhury S, Bailey, S (2015): Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceut. Statist. 15, 123–134. • Renfro LA and SJ Mandrekar (2017): Definitionsand Statistical Properties of Master ProtocolsforPersonalized Medicine in Oncology. Journal ofBiopharmaceuticalStatistics 28(2), 217-228. • Viele K, Berry S, Neuenschwander B et al. (2014): Useofhistoricalcontroldataforassessingtreatmenteffects in clinicaltrials. PharmaceuticalStatistics 13, 41-54. Exploring early interim analyses in basket designs in Oncology, 24 May 2019
Questions? Optional subtitle